The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 2, 1999, Pages 253-259

  Schmitz, Franz Josef ^a   Fluit, Ad C ^b   Gondolf, Mechthild ^a   Beyrau, Ralf ^a   Lindenlauf, Elke ^a   Verhoef, Jan ^b   Heinz, Hans Peter ^a   Jones, Mark E ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; GENTAMICIN; KANAMYCIN; METICILLIN; STREPTOMYCIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL GENE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; EUROPE; GEOGRAPHIC DISTRIBUTION; NONHUMAN; PENICILLIN RESISTANCE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; WOUND INFECTION;

ACETYLTRANSFERASES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COAGULASE; DRUG RESISTANCE, MICROBIAL; EUROPE; GENTAMICINS; HOSPITALS; KANAMYCIN; KANAMYCIN KINASE; METHICILLIN RESISTANCE; NUCLEOTIDYLTRANSFERASES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOMYCIN; TOBRAMYCIN;

EID: 0033043536     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.2.253     Document Type: Article

References (20)

1. Dornbusch, K., Miller, G. H., Hare, R. S. & Shaw, K. J. (1990). Resistance to aminoglycoside antibiotics in Gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR study group (European Study Group on Antibiotic Resistance). Journal of Antimicrobial Chemotherapy 26, 131-44.
2. European Study Group on Antibiotic Resistance. (1987). In-vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories. European Journal of Clinical Microbiology 6, 378-85.
3. Wildemauwe, C., Godard, C., Vanhoof, R., Bossuyt, E. V. & Hannecart-Pokorni, E. (1996). Changes in major populations of methicillin-resistant Staphylococcus aureus in Belgium. Journal of Hospital Infection 34, 197-203.
4. Schmitz, F.-J. & Jones, M. E. (1997). Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? International Journal of Antimicrobial Agents 9, 1-19.
5. Paulsen, I. T., Firth, N. & Skurray, R. A. (1997). Resistance to antimicrobial agents other than β-lactams. In The Staphylococci in Human Disease (Crossley, K. B. & Archer, G. L., Eds), pp. 175-212. Churchill Livingstone, New York.
6. Ubukata, K., Yamashita, N., Gotoh, A. & Konno, M. (1984). Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy 25, 754-9.
7. Matsumara, M., Katakura, T., Imanaka, T. & Aiba, S. (1984). Enzymatic and nucleotide sequence studies of a kanamycin-inactivating enzyme encoded by a plasmid from thermophilic bacilli in comparison with that encoded by plasmid pUB110. Journal of Bacteriology 160, 413-20.
8. Stewart, P. R., Dubin, D. T., Chikramane, S. G., Inglis, B., Matthews, P. R. & Poston, S. M. (1994). IS257 and small plasmid insertions in the mec region of the chromosome of Staphylococcus aureus. Plasmid 31, 12-20.
9. Archer, G. L. & Niemeyer, D. M. (1994). Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends in Microbiology 2, 343-7.
10. Byrne, M. E., Gillespie, M. T. & Skurray, R. A. (1991). 4′,4″-adenyltransferase activity on conjugative plasmids isolated from Staphylococcus aureus is encoded on an integrated copy of pUB110. Plasmid 25, 70-5.
11. Derbise, A., Dyke, K. G. H. & el Solh, N. (1996). Characterization of a Staphylococcus aureus transposon Tn5405, located within Tn5404 carrying the aminoglycoside resistance genes, aphA-3 and aadE. Plasmid 35, 74-88.
12. Phillips, I. & Shannon, K. (1984). Aminoglycoside resistance. British Medical Bulletin 40, 28-35.
13. Courvalin, P. & Fiandt, M. (1980). Aminoglycoside-modifying enzymes of Staphylococcus aureus: expression in Escherichia coli. Gene 9, 247-69.
14. Projan, S. J., Moghazeh, S. & Novick, R. P. (1988). Nucleotide sequence of pS194, a streptomycin-resistance plasmid from Staphylococcus aureus. Nucleic Acids Research 16, 2179-87.
15. Schmitz, F.-J., Lindenlauf, E., Hofmann, B., Fluit, A. C., Verhoef, J., Heinz, H. P. et al. (1998). The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. Journal of Antimicrobial Chemotherapy 42, 489-95.
16. National Committee for Clinical Laboratory Standards. (1993). Performance Standards for Antimicrobial Disk Susceptibility Tests - Fifth Edition: Approved Standard M2-A5. NCCLS, Villanova, PA.
17. Schmitz, F.-J., Mackenzie, C. R., Hofmann, B., Verhoef, J., Finken-Eigen, M., Heinz, H. P. et al. (1997). Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR. Journal of Medical Microbiology 46, 773-8.
18. Vanhoof, R., Godard, C., Content, J., Nyssen, H. J. & Hannecart-Pokorni, E. (1994). Detection by polymerase chain reaction of genes encoding aminoglycoside-modifying enzymes in methicillin-resistant Staphylococcus aureus isolates of epidemic phage types. Journal of Medical Microbiology 41, 282-90.
19. Bengtsson, S., Bernander, S., Brorson, J. E., Dornbusch, K., Forsgren, A., Hallander, H. et al. (1986). In-vitro aminoglycoside resistance of Gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984. Scandinavian Journal of Infectious Diseases 18, 257-63.
20. Jaffe, H. W., Sweeney, H. M., Weinstein, R. A., Kabins, S. A, Nathan, C. & Cohen, S. (1982). Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococci. Antimicrobial Agents and Chemotherapy 21, 773-9.